AstraZeneca’s Potential Blockbuster Pill Halves High Cholesterol

Byadmin
AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes for a potential blockbuster that could be part of a powerful combination medicine targeting weight-loss and related co-morbidities.

Similar Posts

Trump Has Showman Instinct: Tai on Tariff Announcement

Byadmin
Katherine Tai, Former US Trade Representative under the Biden Administration, discusses what the best and worst scenarios may be when President Trump unveils his tariff plan on Wednesday April 2nd. She also weighs in on countries like Canada and others suggesting they will place retaliatory measures on the United States and what this means from a geopolitical standpoint. Katherine Tai speaks with Kailey Leinz and Joe Mathieu on Bloomberg’s “Balance of Power: Late Edition.” (Source: Bloomberg)